Literature DB >> 27283386

The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations.

Yurong Wang1, Li Liu2, Lihong Xin2, Dazhi Fan2, Ning Ding2, Yanting Hu2, Guoqi Cai2, Li Wang2, Qing Xia2, Xiaona Li2, Xiao Yang2, Yanfeng Zou2, Faming Pan3.   

Abstract

It has been reported that two single nucleotide polymorphisms (SNP) Taq1A and -141C Ins/Del in the DRD2 gene may be associated with susceptibility to schizophrenia. Due to inconclusive and mixed results, a meta-analysis was conducted to further clarify the relationship between the two SNP and schizophrenia susceptibility. A systematic literature search for the association of these two SNP with schizophrenia susceptibility was conducted using PubMed, ScienceDirect, Chinese Biomedical Literature Database, and Chinese National Knowledge Infrastructure. Odds ratios (OR) with 95% confidence intervals (CI) were used to assess the strength of the associations reported. A total of 5558 schizophrenic patients and 6792 healthy controls from 31 articles were included in this study. Evidence regarding the association between -141C Ins/Del polymorphism and schizophrenia was found in the allele frequency comparison (Ins versus Del: OR 1.29, 95% CI 1.06-1.57; p=0.01, Praw=0.1, PFalse Discovery Rate=0.023). In ethnic subgroup analysis, the result revealed that the 141C Ins/Del polymorphism was associated with schizophrenia in all genetic models in Asians, but not in Caucasians. For Taq1A polymorphism, a significant association was found in the allele frequency (A1 versus A2: OR 0.71, 95% CI 0.52-0.98, p=0.03). Stratification by ethnicity indicated an association between the Taq1A polymorphism and schizophrenia in Asians, but not Caucasians. The present study suggests that the -141C Ins/Del polymorphism carries a significantly increased risk of schizophrenia, while the Taq1A polymorphism carries a significantly decreased risk of schizophrenia susceptibility in Asians.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  -141C Ins/Del; DRD2; Meta-analysis; Schizophrenia; Taq1A

Mesh:

Substances:

Year:  2016        PMID: 27283386     DOI: 10.1016/j.jocn.2015.10.052

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Successful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study.

Authors:  Hongying Chen; Yong Fan; Lei Zhao; Yong Hao; Xiajun Zhou; Yangtai Guan; Zezhi Li
Journal:  Brain Behav       Date:  2017-08-13       Impact factor: 2.708

2.  Association between DRD2 and ANKK1 polymorphisms with the deficit syndrome in schizophrenia.

Authors:  Anna Michalczyk; Justyna Pełka-Wysiecka; Jolanta Kucharska-Mazur; Michał Wroński; Błażej Misiak; Jerzy Samochowiec
Journal:  Ann Gen Psychiatry       Date:  2020-06-17       Impact factor: 3.455

3.  No association between polymorphisms in the promoter region of dopamine receptor D2 gene and schizophrenia in the northern Chinese Han population: A case-control study.

Authors:  Xi-Cen Zhang; Mei Ding; Atif Adnan; Yi Liu; Yong-Ping Liu; Jia-Xin Xing; Jin-Feng Xuan; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  Brain Behav       Date:  2019-01-18       Impact factor: 2.708

4.  Association of expression of DRD2 rs1800497 polymorphism with migraine risk in Han Chinese individuals.

Authors:  Yingfeng Deng; Jianping Huang; Huijun Zhang; Xueqin Zhu; Qin Gong
Journal:  J Pain Res       Date:  2018-04-12       Impact factor: 3.133

5.  Evaluation of association of DRD2 TaqIA and -141C InsDel polymorphisms with food intake and anthropometric data in children at the first stages of development.

Authors:  Vanessa Feistauer; Márcia R Vitolo; Paula D B Campagnolo; Vanessa S Mattevi; Silvana Almeida
Journal:  Genet Mol Biol       Date:  2018-07-23       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.